The China chief of AstraZeneca - Britain's biggest company - was arrested months ago, but his condition and whereabouts remain a mystery ...

Morgans healthcare and life sciences expert Iain Wilkie fills in for Scott Power this week, covering what the health movers ...

Sino Biopharm will buy the 95.1 percent of the Chinese developer of novel biologic drugs for cancer treatment that it does not already own, the Beijing-based company announced late on July 15. LaNova ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...

The FTSE 100 index of leading shares has broken through 9,000 for the first time. That’s not as impressive as it ...

BEIJING: US bank Wells Fargo told AFP Friday it was working to help one of its employees return to the United States, after ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...

Bitcoin Miners Dominate the List. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of Wednesday’s top performers. Summit ...

Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...